Topical Tofacitinib for Patients with Lichen Planopilaris and/or Frontal Fibrosing Alopecia
February 2024
in “
Journal of the American Academy of Dermatology
”
TLDR Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.
The document discusses the potential of topical tofacitinib, a JAK-1/3 inhibitor, as a treatment for lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA), which are forms of cicatricial alopecia. While oral JAK inhibitors have been used to treat these conditions, they carry risks of serious infections. Topical formulations, such as tofacitinib 2% cream, may offer a safer alternative. The document highlights two cases of women with FFA who showed improvement with this topical treatment, suggesting its potential efficacy with reduced systemic risks.